1h Free Analyst Time
The point of care (POC) haematology diagnostics market is forecasted to grow by USD 4.67 billion during 2023-2028, accelerating at a CAGR of 12.55% during the forecast period. The report on the point of care (POC) haematology diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of blood disorders and infectious disease, increasing growth in poc hematology diagnostics product launches, and paradigm shift from benchtop to portable hematology diagnostic systems.
The point of care (POC) haematology diagnostics market is segmented as below:
By Product
- Consumables
- Systems
By End-user
- Hospitals and clinics
- Homecare settings
- Clinical diagnostic laboratories
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the point of care (POC) haematology diagnostics market covers the following areas:
- Point Of Care (POC) Haematology Diagnostics Market sizing
- Point Of Care (POC) Haematology Diagnostics Market forecast
- Point Of Care (POC) Haematology Diagnostics Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Additional Value/Volume Data
6 Five Forces Analysis
7 Market Segmentation by Product
8 Market Segmentation by End-user
9 Customer Landscape
10 Geographic Landscape
11 Drivers, Challenges, and Opportunity/Restraints
12 Competitive Landscape
13 Competitive Analysis
14 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global point of care (POC) haematology diagnostics market: A. Menarini Industrie Farmaceutiche Riunite Srl, Abbott Laboratories, Chengdu Seamaty Technology Co. Ltd., Danaher Corp., DIAGON Kft., Diamond Diagnostics, Drucker Diagnostics LLC, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., HORIBA Ltd., Medsource Ozone Biomedicals Pvt. Ltd., Norma Instruments Zrt., Nova Biomedical Corp., PixCell Medical Technologies Ltd., S.D. Sight Diagnostics Ltd., Sekisui Diagnostics LLC, Shenzhen Mindray BioMedical Electronics Co. Ltd, Siemens AG, Sysmex Corp., and Transasia Bio Medicals Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increase in online marketing."
According to the report, one of the major drivers for this market is the increasing prevalence of blood disorders and infectious disease.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- A. Menarini Industrie Farmaceutiche Riunite Srl
- Abbott Laboratories
- Chengdu Seamaty Technology Co. Ltd.
- Danaher Corp.
- DIAGON Kft.
- Diamond Diagnostics
- Drucker Diagnostics LLC
- EKF Diagnostics Holdings Plc
- F. Hoffmann La Roche Ltd.
- HORIBA Ltd.
- Medsource Ozone Biomedicals Pvt. Ltd.
- Norma Instruments Zrt.
- Nova Biomedical Corp.
- PixCell Medical Technologies Ltd.
- S.D. Sight Diagnostics Ltd.
- Sekisui Diagnostics LLC
- Shenzhen Mindray BioMedical Electronics Co. Ltd
- Siemens AG
- Sysmex Corp.
- Transasia Bio Medicals Ltd.
